RxDoctor Payments Data

Wayne Bixenman, MD

Neuro-ophthalmology · Tucson, AZNPI 1790862522

Payments from drug & device makers

$511in general payments, 2019–2025

Across 38 payments — averaging $13.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$386
  • Glaukos Corporation$65
  • Alcon$25
  • Kala Pharmaceuticals, Inc.$22
  • Amgen$13

What the payments were for

  • Food & beverage$511100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis34$386
Glaukos Corporation1$65
Alcon1$25
Kala Pharmaceuticals, Inc.1$22
Amgen1$13

How this compares

Too few neuro-ophthalmology providers in Arizonato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$149,185
Medicare patients
476
Services billed
1,919

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pyridostigmine Bromide11$951
Prednisolone Acetate17$676
Latanoprost30$153
Prednisone12$85

Paid to pharmacies, not to this prescriber.

Other neuro-ophthalmology in Tucson

Where these figures come from

Is this you, or does something look wrong? →